Jefferies lowered the firm’s price target on Clorox (CLX) to $145 from $167 and keeps a Buy rating on the shares, telling investors that the next two quarters “will be complicated to model” as shipping timing ahead of Clorox’s U.S. ERP rollout and wind down will “create operating leverage and deleverage that surprises.” The firm, which expects Clorox to guide to down 4% to down 2% organic sales and a low-teens percentage EPS decline for FY26, thinks consensus estimates need a “recalibration” as numbers are “too high.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX: